par Esteban, Emilio;Villanueva, Noemi;Muñiz, Isabel;Fernández, Yolanda;Fra, Joaquin;Luque, Maria;Jiménez, Paula;Llorente, Beatriz;Capelan, Marta ;Vieitez, José M;Estrada, Enrique;Buesa, José M;Jiménez-Lacave, Angel
Référence Investigational new drugs, 26, 1, page (67-74)
Publication Publié, 2008-02
Référence Investigational new drugs, 26, 1, page (67-74)
Publication Publié, 2008-02
Article révisé par les pairs
Titre: |
|
Auteur: | Esteban, Emilio; Villanueva, Noemi; Muñiz, Isabel; Fernández, Yolanda; Fra, Joaquin; Luque, Maria; Jiménez, Paula; Llorente, Beatriz; Capelan, Marta; Vieitez, José M; Estrada, Enrique; Buesa, José M; Jiménez-Lacave, Angel |
Informations sur la publication: | Investigational new drugs, 26, 1, page (67-74) |
Statut de publication: | Publié, 2008-02 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Cancérologie | |
MeSH keywords: | Adult |
Aged | |
Anemia -- chemically induced | |
Antineoplastic Combined Chemotherapy Protocols -- adverse effects -- therapeutic use | |
Carcinoma, Non-Small-Cell Lung -- drug therapy -- pathology | |
Deoxycytidine -- administration & dosage -- adverse effects -- analogs & derivatives | |
Diarrhea -- chemically induced | |
Female | |
Humans | |
Lung Diseases -- chemically induced | |
Lung Neoplasms -- drug therapy -- pathology | |
Male | |
Middle Aged | |
Neutropenia -- chemically induced | |
Prospective Studies | |
Taxoids -- administration & dosage -- adverse effects | |
Time Factors | |
Treatment Outcome | |
Vinblastine -- administration & dosage -- adverse effects -- analogs & derivatives | |
Note générale: | Clinical Trial, Phase II |
Journal Article | |
Randomized Controlled Trial | |
Langue: | Anglais |
Identificateurs: | urn:issn:0167-6997 |
info:doi/10.1007/s10637-007-9073-4 | |
info:pmid/17805486 |